The DOI matches its Crossref record.
Brain metastasis from renal cell carcinoma: Presentation, recurrence, and survival
Open accessAbstract
BACKGROUND.: Patients with renal cell carcinoma brain metastases (RCCBM) are frequently excluded from trials and to the authors' knowledge no guidelines currently exist regarding central nervous system (CNS) surveillance or treatment. The objective of the current study was to assist in the creation of treatment guidelines. METHODS.: Patients undergoing evaluation for RCCBM from 1989 to 2006 were identified. Their characteristics, symptoms, pathologic variables, number and size of RCCBM, CNS treatment, CNS recurrence, overall survival, and use of systemic therapy were reviewed. RESULTS.: A total of 138 patients were identified with RCCBM, of whom 92% had clear cell RCC and 95% had synchronous extracranial metastases. CNS symptoms were noted in 67% of patients. Symptomatic CNS tumors were larger (2.1 cm vs 1.3 cm; P < .001) and more frequently required a craniotomy (P < .001). The median overall survival after a diagnosis of RCCBM was 10.7 months; the 1‐year, 2‐year, and 5‐year survival rates were 48%, 30%, and 12%, respectively. Median CNS recurrence was 9 months after RCCBM treatment. The initial number of tumors (>1 tumor) was found to be an independent predictor of CNS recurrence (hazards ratio of 3.72; P < .001). Those patients with 1 and >1 lesion had a median CNS recurrence‐free survival of 13 months and 4 months, respectively (P < .001). Patients receiving interleukin‐2 after CNS treatment had a response rate of 17%. CONCLUSIONS.: Patients with metastatic RCC should undergo CNS screening to allow the identification of smaller lesions that are more amenable to treatment. Those patients with solitary RCCBM are less likely to develop CNS recurrence after local therapy. Selected patients with good performance status may exhibit prolonged survival and should be offered aggressive therapy. Cancer 2008. © 2008 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
Bianchi, M., Sun, M., Jeldres, C., Shariat, S. F., Trinh, Q.-D., Briganti, A., Tian, Z., Schmitges, J., Graefen, M., Perrotte, P., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr362 · Cited by 653
Brain metastases: epidemiology
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-811161-1.00002-5 · Cited by 336
Local treatments for metastases of renal cell carcinoma: a systematic review
Dabestani, S., Marconi, L., Hofmann, F., Stewart, F., Lam, T. B. L., Canfield, S. E., Staehler, M., Powles, T., Ljungberg, B., & Bex, A. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70235-9 · Cited by 318
Harter, P. N., Zinke, J., Scholz, A., Tichy, J., Zachskorn, C., Kvasnicka, H. M., Goeppert, B., Delloye-Bourgeois, C., Hattingen, E., Senft, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092311 · Cited by 41
Metadata
- Authors
- Shuch, B., La Rochelle, J. C., Klatte, T., Riggs, S. B., Liu, W., Kabbinavar, F. F., Pantuck, A. J., & Belldegrun, A. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2008-07-31
- Volume
- 113
- Issue
- 7
- Pages
- 1641-1648
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1980559829
- Cited by
- 163
- References
- 0
- FWCI
- 8.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brain metastasis from renal cell carcinoma: Presentation, recurrence, and survival. https://app.cochat.ai/papers/10.1002/cncr.23769
- The paper
- Shuch, B., La Rochelle, J. C., Klatte, T., Riggs, S. B., Liu, W., Kabbinavar, F. F., Pantuck, A. J., & Belldegrun, A. S. (2008). Brain metastasis from renal cell carcinoma: Presentation, recurrence, and survival. Cancer. https://doi.org/10.1002/cncr.23769
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.